Medplus Health Services legal & regulatory announcements

Every Medplus Health Services legal & regulatory announcement on NSE and BSE, newest first, each with its own page.

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

5 announcements with these filters

17 Oct 2026 14:32 IST BSE

Legal & Regulatory Medplus Health Services Ltd MEDPLUS

Medplus Health Services Legal & Regulatory

Medplus Health Services reported a 15-day drug license suspension for a subsidiary store by the FDA, with an estimated financial impact of ₹0.14 Crore.

Value: ₹0.14 Cr
From: Food and Drug Administration, Mumbai, Maharashtra
Execution: 15 days

Open announcement → Read the filing ↗

9 Oct 2026 18:21 IST NSE

Legal & Regulatory Medplus Health Services Ltd MEDPLUS

Medplus Health Services Legal & Regulatory

Medplus Health Services reported a one-day drug license suspension at a Telangana store due to compliance violations. The estimated financial impact is Rs 0.001 Crore.

Value: ₹0.00 Cr
Execution: 01 day

Open announcement → Read the filing ↗

8 Oct 2026 18:04 IST NSE

Legal & Regulatory Medplus Health Services Ltd MEDPLUS

Medplus Health Services Legal & Regulatory

Medplus Health's subsidiary, Optival Health, received a 4-day drug license suspension at its Udala, Odisha store. The financial impact is estimated at Rs 0.02 Crore.

Value: ₹0.02 Cr
Execution: 4 days

Open announcement → Read the filing ↗

7 Oct 2026 17:11 IST BSE

Legal & Regulatory Medplus Health Services Ltd MEDPLUS

Medplus Health Services Legal & Regulatory

MedPlus Health Services reported a 7-day drug license suspension for its subsidiary Optival Health Solutions. The action carries an estimated financial impact of Rs 0.12 Crore.

Value: ₹0.12 Cr
From: Assistant Director Drugs Control Administration, Mangalore Circle
Execution: 7 days

Open announcement → Read the filing ↗

1 Oct 2026 17:17 IST BSE

Legal & Regulatory Medplus Health Services Ltd MEDPLUS

Medplus Health Services Legal & Regulatory

The Food & Drug Administration suspended the drug license of a MedPlus subsidiary store in Nashik for 15 days. The expected financial impact is Rs 0.042 Crore.

Value: ₹0.04 Cr
Execution: 15 days

Open announcement → Read the filing ↗